Omeza Collagen Matrix is FDA 510(k)-cleared and explicitly indicated for post-Mohs surgical wounds — designed to conform to irregular wound beds, protect the site, and support the natural healing process with a simple in-office HCP application.
Omeza Collagen Matrix is an amorphous, conforming wound matrix designed for intimate contact with the wound bed. Unlike flat sheet products, OCM is engineered to fit the irregular topography that Mohs surgeons and dermatologists actually encounter — protecting the site and supporting orderly repair from the moment it's applied.
Product description summarized from official IFU and OCM page. IFU OCM page
OCM is positioned to address the key biological needs across all phases of wound healing — something most single-mechanism products cannot provide. Source
Covers the wound and provides a physical barrier and protective environment that supports the natural healing process from the first application.
Designed for intimate contact with both regular and irregular wound beds — distributed evenly across the wound site for complete coverage.
Supports proliferation, tissue signaling, and remodeling — providing scaffolding so skin can regrow on an organized structural framework.
Addresses biofilm formation in the wound environment, supporting a cleaner wound bed where healing can progress without interference.
Phase descriptions summarized from official Omeza OCM product page. Source
Omeza's official Instructions for Use list surgical wounds, including post-Mohs surgery, among the product's indicated uses. IFU
OCM's indication list covers the full spectrum of surgical and complex wound settings.
Post-excision defects, irregular wound beds, and complex facial anatomy that demand a conforming matrix.
Surgical wounds, post-laser surgery, skin tears, and venous stasis ulcers in a dermatology office setting.
Complex reconstructive cases, graft sites, donor sites, and surgical wounds requiring organized wound management.
Chronic and complex wound management at scale, with a product indicated across multiple wound categories.
Podiatric wounds, diabetic foot ulcers, and post-surgical wound management in the lower extremity setting.
Post-operative wounds, vascular ulcers, wound dehiscence, and complex wound situations following vascular procedures.
Surgical wound management, wound dehiscence, and trauma wounds across a general or hospital-based surgical practice.
Wound management resources for physicians supporting patients with chronic and post-procedural wounds.
Feedback from clinicians managing real patients across wound care settings. Source
"Omeza collagen matrix is easily applied, easily maintained and nearly every patient with whom we've used it has gone on to improvement or full healing within the 3rd or 4th application."
"After the first two treatments, I was most impressed by the positive qualitative change to the wound bed with robust granulation tissue forming. The wound quickly epithelialized and was healed."
"After 37 years of wound care experience, having tried everything in a wound care center setting, I can only suggest drop what you are using and try Omeza. The results are astounding."
"Variable application concept, lidocaine, collagen (matrix), skin protectant, with an easy application process. Amazing results for my patients with chronic non-healing wounds!"
"After about three months of using Omeza, I can finally say my patient's wound is healed. The patient's wound had stalled in healing, and this amazing product definitely helped kickstart the healing process."
"The response to the Omeza treatment protocol was greater than expected and healed 3 wounds that were present for greater than a year."
Omeza's safety program covers human skin testing, repeat insult patch testing, porcine wound-healing studies, sterilization validation, endotoxin testing, viral inactivation work, collagen characterization, and shelf-life data.
The strongest physician-facing message is that OCM is indicated for post-Mohs surgical wounds, designed for intimate wound-bed contact, and supported by safety and bench testing. Product-specific claims around healing speed or cosmesis should be reviewed carefully before use in marketing. Source
Written to be conversion-friendly while staying close to official product documentation.
Fortify Medical is an authorized distributor of Omeza OCM, dedicated to supporting wound care practices nationwide with clinical resources, reimbursement guidance, and direct representative access.
Medical Consultant
M.B.A — Healthcare Administration
Medical Sales Executive
Fortify Medical provides product information, clinical resources, reimbursement guidance, and direct representative support to wound care practices nationwide. Our representative, Ben Barton, handles direct practice inquiries with a 24‑hour response commitment.
Start with the product explicitly indicated for post-Mohs surgery — designed for intimate wound-bed contact, protected healing support, and clinician-directed application.